Dementia researchers downplay Novo announcement: Let us see some data

Two of the country's leading researchers in dementia and Alzheimer's disease have been critical about the two announcements from Novo Nordisk about a possible breakthrough within Alzheimer's. It is a premature announcement, and Novo Nordisk hasn't presented concete data, they say. "I wouldn't give it too much weight," says consultant and professor Steen Gregers Hasselbach.

The lack of presented data means Gunhild Waldemar, professor, consultant and leader of the National Knowledge Center for Dementia is skeptical about annuncements of a breakthrough. Photo: Nationalt Videnscenter for Demens / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles